Mega Cap Healthcare
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
1
Eli Lilly
LLY
$1.02T
| $1.02T | $1,148.84 | 0.53% |
|
2
Johnson & Johnson
JNJ
$618B
| $618B | $256.35 | 0.21% |
|
3
AbbVie
ABBV
$443B
| $443B | $250.94 | 2.51% |
|
4
UnitedHealth
UNH
$376B
| $376B | $414.40 | 1.68% |
|
5
Merck
MRK
$322B
| $322B | $130.20 | 0.32% |
|
6
Novartis
NVS
$297B
| $297B | $156.15 | 1.45% |
|
7
AstraZeneca
AZN
$263B
| $263B | $169.64 | 0.99% |
|
8
Thermo Fisher Scientific
TMO
$213B
| $213B | $574.30 | 0.43% |
|
|
NVO
9
Novo Nordisk
NVO
$208B
| $208B | $47.08 | 8.78% |
|
10
Amgen
AMGN
$208B
| $208B | $385.16 | 0.64% |
|
Mega Cap Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 10 mega cap Healthcare stocks — companies in the Healthcare sector with a market cap over $200B — worth a combined $3.97T.
The largest by market cap are Eli Lilly (LLY) at $1.02T, Johnson & Johnson (JNJ) at $618B and AbbVie (ABBV) at $443B.
Among institutional investors, Merck (MRK) drew the most net new fund positions in Q1 2026: 315 funds opened new positions, taking total fund holders up 128 (3.5%) quarter-over-quarter.
- Combined market cap: $3.97T across 10 stocks.
- Mega Cap: market cap over $200B.
- Largest constituent: Eli Lilly (LLY), $1.02T market cap.
- Most net new fund positions in Q1 2026: Merck (MRK), +128 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.